Evidence map›Paper›PMID 42564652›Full record

ArticleCase reports in urology2026

Pleomorphic Giant Cell Carcinoma of the Prostate Treated With Lutetium-177 PSMA.

John Y Kwon, John C Cheville, Miguel Muniz-Rincon, Mohamed E Ahmed, Eugene D Kwon, Irbaz Riaz, Dan S Childs, Geoffrey Johnson, Oliver Sartor, Lance C Pagliaro and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Case reports in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

John Y KwonDepartment of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.ORCID https://orcid.org/0009-0004-2886-4772
John C ChevilleDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.ORCID https://orcid.org/0000-0002-8202-6268
Miguel Muniz-RinconDepartment of Oncology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.ORCID https://orcid.org/0009-0004-7268-5077
Mohamed E AhmedDepartment of Urology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
Eugene D KwonDepartment of Urology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.
Irbaz RiazDepartment of Internal Medicine, Division of Oncology, Mayo Clinic, Phoenix, Arizona, USA, mayo.edu.ORCID https://orcid.org/0000-0003-4249-0311
Dan S ChildsDepartment of Oncology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.ORCID https://orcid.org/0000-0001-7643-2836
Geoffrey JohnsonDepartment of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.ORCID https://orcid.org/0000-0002-9781-4072
Oliver SartorDepartment of Oncology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.ORCID https://orcid.org/0000-0002-8777-7343
Lance C PagliaroDepartment of Oncology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.ORCID https://orcid.org/0000-0002-4209-3394
Jacob J OrmeDepartment of Oncology, Mayo Clinic, Rochester, Minnesota, USA, mayo.edu.ORCID https://orcid.org/0000-0002-0319-0239

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pleomorphic giant cell carcinoma (PGCC) of the prostate is an extremely rare and aggressive malignancy with limited treatment options. We present a case report of metastatic PGCC patients treated with

Indexed as

lutetium-177-PSMAPGCCpleomorphic giant cellpleomorphic giant cell carcinomaPluvictoprostate cancerradioligand therapy

Identifiers

PMID42564652
PMCPMC13443711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.